MX2014012837A - Intermediarios y procesos para preparar compuestos. - Google Patents

Intermediarios y procesos para preparar compuestos.

Info

Publication number
MX2014012837A
MX2014012837A MX2014012837A MX2014012837A MX2014012837A MX 2014012837 A MX2014012837 A MX 2014012837A MX 2014012837 A MX2014012837 A MX 2014012837A MX 2014012837 A MX2014012837 A MX 2014012837A MX 2014012837 A MX2014012837 A MX 2014012837A
Authority
MX
Mexico
Prior art keywords
processes
intermediates
preparing compounds
preparation
compounds
Prior art date
Application number
MX2014012837A
Other languages
English (en)
Other versions
MX349255B (es
Inventor
Chong Han
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MX2014012837A publication Critical patent/MX2014012837A/es
Publication of MX349255B publication Critical patent/MX349255B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La invención proporciona intermediarios y procesos de preparación de los mismos, útiles en la preparación de compuestos que pueden utilizarse como inhibidores de la CHK1.
MX2014012837A 2012-04-23 2013-04-22 Intermediarios y procesos para preparar compuestos. MX349255B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261637170P 2012-04-23 2012-04-23
PCT/US2013/037646 WO2013163109A1 (en) 2012-04-23 2013-04-22 Intermediates and processes for preparing compounds

Publications (2)

Publication Number Publication Date
MX2014012837A true MX2014012837A (es) 2015-10-22
MX349255B MX349255B (es) 2017-07-19

Family

ID=48289659

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014012837A MX349255B (es) 2012-04-23 2013-04-22 Intermediarios y procesos para preparar compuestos.

Country Status (17)

Country Link
US (1) US9221813B2 (es)
EP (1) EP2855473B1 (es)
JP (2) JP6370772B2 (es)
KR (1) KR102096679B1 (es)
CN (1) CN104395311B (es)
AR (1) AR090789A1 (es)
AU (1) AU2013252514B2 (es)
BR (1) BR112014026367A2 (es)
CA (1) CA2871436C (es)
IL (1) IL235234B (es)
MX (1) MX349255B (es)
MY (1) MY168958A (es)
NZ (1) NZ702135A (es)
RU (1) RU2635359C2 (es)
SG (1) SG11201406818VA (es)
WO (1) WO2013163109A1 (es)
ZA (1) ZA201408568B (es)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543523A (en) 1994-11-15 1996-08-06 Regents Of The University Of Minnesota Method and intermediates for the synthesis of korupensamines
GB0400781D0 (en) * 2004-01-14 2004-02-18 Novartis Ag Organic compounds
CA2589779A1 (en) * 2004-12-23 2006-06-29 F. Hoffmann-La Roche Ag Benzamide substituted imidazo- and pyrolo-pyridines as protein kinase inhibitors
NZ565255A (en) * 2005-06-22 2010-04-30 Plexxikon Inc Pyrrolo[2,3-b] pyridine derivatives as protein kinase inhibitors
CN101223168A (zh) * 2005-07-14 2008-07-16 安斯泰来制药株式会社 Janus激酶3的杂环类抑制剂
ES2526813T3 (es) * 2005-12-22 2015-01-15 Cancer Research Technology Limited Inhibidores de enzimas
WO2008144253A1 (en) 2007-05-14 2008-11-27 Irm Llc Protein kinase inhibitors and methods for using thereof
ES2394759T3 (es) 2008-01-08 2013-02-05 Array Biopharma, Inc. Pirrolopiridinas como inhibidores de quinasa
CN101965347B (zh) 2008-01-09 2013-01-02 阵列生物制药公司 作为激酶抑制剂的吡唑并吡啶
JP5419894B2 (ja) * 2008-01-11 2014-02-19 グレンマーク ファーマシューティカルズ, エセ.アー. Trpv3モジュレーターとしての縮合ピリミジン誘導体
AR071717A1 (es) * 2008-05-13 2010-07-07 Array Biopharma Inc Pirrolo[2,3-b]piridinas inhibidoras de quinasas chk1 y chk2,composiciones farmaceuticas que las contienen,proceso para prepararlas y uso de las mismas en el tratamiento y prevencion del cancer.
KR101764556B1 (ko) * 2008-06-11 2017-08-02 제넨테크, 인크. 디아자카르바졸 및 사용 방법
GB201201566D0 (en) * 2012-01-30 2012-03-14 Vernalis R&D Ltd New chemical compounds

Also Published As

Publication number Publication date
MY168958A (en) 2019-01-28
CA2871436C (en) 2020-07-28
WO2013163109A1 (en) 2013-10-31
IL235234B (en) 2018-01-31
AU2013252514A1 (en) 2014-12-11
RU2014147003A (ru) 2016-06-10
JP2015514784A (ja) 2015-05-21
SG11201406818VA (en) 2014-11-27
KR102096679B1 (ko) 2020-04-02
US20150105557A1 (en) 2015-04-16
KR20150005995A (ko) 2015-01-15
JP2018058841A (ja) 2018-04-12
CA2871436A1 (en) 2013-10-31
RU2635359C2 (ru) 2017-11-13
BR112014026367A2 (pt) 2017-06-27
AR090789A1 (es) 2014-12-10
CN104395311B (zh) 2017-04-19
CN104395311A (zh) 2015-03-04
NZ702135A (en) 2016-09-30
EP2855473B1 (en) 2018-10-03
AU2013252514B2 (en) 2017-07-20
JP6370772B2 (ja) 2018-08-08
MX349255B (es) 2017-07-19
EP2855473A1 (en) 2015-04-08
ZA201408568B (en) 2017-05-31
US9221813B2 (en) 2015-12-29

Similar Documents

Publication Publication Date Title
IN2015DN00127A (es)
HK1210957A1 (en) Effluz inhibitor compositions and methods of treatment using the same
HK1207861A1 (en) Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancer bub1
PH12015500525A1 (en) Formulations of enzalutamide
MX2022000026A (es) Anticuerpos para tau.
MX2015006324A (es) Metodos para la fabricacion de polipeptidos proteoliticamente procesados.
MX355728B (es) Inhibidores de cinasas.
MX2013015311A (es) Polipeptidos de enlace de pcsk9 y metodos de uso.
MX2020001756A (es) Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos.
HK1206264A1 (en) Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof -3-
PH12014501605A1 (en) Anti-lrp5 antibodies and methods of use
ZA201408056B (en) Compositions and methods for the treatment of mucositis
SG10201703051WA (en) Compounds and methods for the production of suckerin and uses thereof
MX2015001506A (es) Proceso e intermediarios para preparar inhibidores de integrasa.
IN2014DN09450A (es)
IN2013MU00848A (es)
IN2014CN04050A (es)
IN2013MU03641A (es)
MX2014015039A (es) Inhibidores de fbx03.
AU2015311730A8 (en) CaMKII inhibitors and uses thereof
IN2014DN00254A (es)
MX2015007608A (es) Metodos y composiciones para inhibir cnksr1.
IN2013MU01113A (es)
UA117567C2 (uk) Композиція, яка стимулює лактацію, на основі фосфатидилсерину
MX369174B (es) Proceso para la preparación de un compuesto.

Legal Events

Date Code Title Description
FG Grant or registration